Cargando…

Teleoncology: A Solution for Everyone? A Single-Center Experience with Telemedicine during the Coronavirus Disease 2019 (COVID-19) Pandemic

Since the beginning of the COVID-19 pandemic, the use of telehealth was rapidly implemented without previous evidence. The ONCOTELEMD study aimed to evaluate the opinion of patients attended via telemedicine during this period and to study factors that condition patient preferences on its use. Inclu...

Descripción completa

Detalles Bibliográficos
Autores principales: Ribera, Paula, Soriano, Sandra, Climent, Carla, Vilà, Laia, Macias, Ismael, Fernández-Morales, Luis Antonio, Giner, Julia, Gallardo, Enrique, Palmer, Miquel Angel Segui, Pericay, Carles
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9689494/
https://www.ncbi.nlm.nih.gov/pubmed/36421328
http://dx.doi.org/10.3390/curroncol29110675
_version_ 1784836549165187072
author Ribera, Paula
Soriano, Sandra
Climent, Carla
Vilà, Laia
Macias, Ismael
Fernández-Morales, Luis Antonio
Giner, Julia
Gallardo, Enrique
Palmer, Miquel Angel Segui
Pericay, Carles
author_facet Ribera, Paula
Soriano, Sandra
Climent, Carla
Vilà, Laia
Macias, Ismael
Fernández-Morales, Luis Antonio
Giner, Julia
Gallardo, Enrique
Palmer, Miquel Angel Segui
Pericay, Carles
author_sort Ribera, Paula
collection PubMed
description Since the beginning of the COVID-19 pandemic, the use of telehealth was rapidly implemented without previous evidence. The ONCOTELEMD study aimed to evaluate the opinion of patients attended via telemedicine during this period and to study factors that condition patient preferences on its use. Included patients had a confirmed cancer diagnosis and were contacted by telephone between 13 March and 30 April 2020, in the Medical Oncology Service of Hospital Parc Taulí, Sabadell. A 12-question survey was presented to them between 4 February and 19 April 2021. Statistical analysis was carried out using chi-square and multivariable logistic regression tests. Six hundred forty-six patients were included; 487 responded to the survey. The median age was 68 years (27–90), 55.2% were female. Most patients had a surveillance visit (65.3%) and were diagnosed with colorectal or breast cancer (43% and 26.5%, respectively); 91.8% of patients were satisfied, and 60% would accept the use of telemedicine beyond the pandemic. Patients aged more than 50 years (OR 0.40; 95% CI, 0.19–0.81; p = 0.01) and diagnosed with breast cancer (OR 0.45; 95% CI, 0.26–0.69; p < 0.001) were less predisposed to adopt telehealth in the future. Patients agreed to be informed via telehealth of scan or lab results (62% and 84%, respectively) but not of new oral or endovenous treatments (52% and 33.5%, respectively). Additionally, 75% of patients had a medium or low-null technologic ability, and 51.3% would only use the telephone or video call to contact health professionals. However, differences were found according to age groups (p < 0.0001). In total, patients surveyed were satisfied with telemedicine and believed telehealth could have a role following the COVID-19 pandemic. Moreover, our results remark on the importance of individualizing the use of telehealth, showing relevant data on patient preferences and digital literacy.
format Online
Article
Text
id pubmed-9689494
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-96894942022-11-25 Teleoncology: A Solution for Everyone? A Single-Center Experience with Telemedicine during the Coronavirus Disease 2019 (COVID-19) Pandemic Ribera, Paula Soriano, Sandra Climent, Carla Vilà, Laia Macias, Ismael Fernández-Morales, Luis Antonio Giner, Julia Gallardo, Enrique Palmer, Miquel Angel Segui Pericay, Carles Curr Oncol Article Since the beginning of the COVID-19 pandemic, the use of telehealth was rapidly implemented without previous evidence. The ONCOTELEMD study aimed to evaluate the opinion of patients attended via telemedicine during this period and to study factors that condition patient preferences on its use. Included patients had a confirmed cancer diagnosis and were contacted by telephone between 13 March and 30 April 2020, in the Medical Oncology Service of Hospital Parc Taulí, Sabadell. A 12-question survey was presented to them between 4 February and 19 April 2021. Statistical analysis was carried out using chi-square and multivariable logistic regression tests. Six hundred forty-six patients were included; 487 responded to the survey. The median age was 68 years (27–90), 55.2% were female. Most patients had a surveillance visit (65.3%) and were diagnosed with colorectal or breast cancer (43% and 26.5%, respectively); 91.8% of patients were satisfied, and 60% would accept the use of telemedicine beyond the pandemic. Patients aged more than 50 years (OR 0.40; 95% CI, 0.19–0.81; p = 0.01) and diagnosed with breast cancer (OR 0.45; 95% CI, 0.26–0.69; p < 0.001) were less predisposed to adopt telehealth in the future. Patients agreed to be informed via telehealth of scan or lab results (62% and 84%, respectively) but not of new oral or endovenous treatments (52% and 33.5%, respectively). Additionally, 75% of patients had a medium or low-null technologic ability, and 51.3% would only use the telephone or video call to contact health professionals. However, differences were found according to age groups (p < 0.0001). In total, patients surveyed were satisfied with telemedicine and believed telehealth could have a role following the COVID-19 pandemic. Moreover, our results remark on the importance of individualizing the use of telehealth, showing relevant data on patient preferences and digital literacy. MDPI 2022-11-11 /pmc/articles/PMC9689494/ /pubmed/36421328 http://dx.doi.org/10.3390/curroncol29110675 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Ribera, Paula
Soriano, Sandra
Climent, Carla
Vilà, Laia
Macias, Ismael
Fernández-Morales, Luis Antonio
Giner, Julia
Gallardo, Enrique
Palmer, Miquel Angel Segui
Pericay, Carles
Teleoncology: A Solution for Everyone? A Single-Center Experience with Telemedicine during the Coronavirus Disease 2019 (COVID-19) Pandemic
title Teleoncology: A Solution for Everyone? A Single-Center Experience with Telemedicine during the Coronavirus Disease 2019 (COVID-19) Pandemic
title_full Teleoncology: A Solution for Everyone? A Single-Center Experience with Telemedicine during the Coronavirus Disease 2019 (COVID-19) Pandemic
title_fullStr Teleoncology: A Solution for Everyone? A Single-Center Experience with Telemedicine during the Coronavirus Disease 2019 (COVID-19) Pandemic
title_full_unstemmed Teleoncology: A Solution for Everyone? A Single-Center Experience with Telemedicine during the Coronavirus Disease 2019 (COVID-19) Pandemic
title_short Teleoncology: A Solution for Everyone? A Single-Center Experience with Telemedicine during the Coronavirus Disease 2019 (COVID-19) Pandemic
title_sort teleoncology: a solution for everyone? a single-center experience with telemedicine during the coronavirus disease 2019 (covid-19) pandemic
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9689494/
https://www.ncbi.nlm.nih.gov/pubmed/36421328
http://dx.doi.org/10.3390/curroncol29110675
work_keys_str_mv AT riberapaula teleoncologyasolutionforeveryoneasinglecenterexperiencewithtelemedicineduringthecoronavirusdisease2019covid19pandemic
AT sorianosandra teleoncologyasolutionforeveryoneasinglecenterexperiencewithtelemedicineduringthecoronavirusdisease2019covid19pandemic
AT climentcarla teleoncologyasolutionforeveryoneasinglecenterexperiencewithtelemedicineduringthecoronavirusdisease2019covid19pandemic
AT vilalaia teleoncologyasolutionforeveryoneasinglecenterexperiencewithtelemedicineduringthecoronavirusdisease2019covid19pandemic
AT maciasismael teleoncologyasolutionforeveryoneasinglecenterexperiencewithtelemedicineduringthecoronavirusdisease2019covid19pandemic
AT fernandezmoralesluisantonio teleoncologyasolutionforeveryoneasinglecenterexperiencewithtelemedicineduringthecoronavirusdisease2019covid19pandemic
AT ginerjulia teleoncologyasolutionforeveryoneasinglecenterexperiencewithtelemedicineduringthecoronavirusdisease2019covid19pandemic
AT gallardoenrique teleoncologyasolutionforeveryoneasinglecenterexperiencewithtelemedicineduringthecoronavirusdisease2019covid19pandemic
AT palmermiquelangelsegui teleoncologyasolutionforeveryoneasinglecenterexperiencewithtelemedicineduringthecoronavirusdisease2019covid19pandemic
AT pericaycarles teleoncologyasolutionforeveryoneasinglecenterexperiencewithtelemedicineduringthecoronavirusdisease2019covid19pandemic